Lifeward (LFWD) Free Cash Flow Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.06% |
| Dec 31, 2025 | -7.57% |
| Sep 30, 2025 | -7.82% |
| Jun 30, 2025 | -4.05% |
| Mar 31, 2025 | -4.82% |
| Dec 31, 2024 | -1.95% |
| Sep 30, 2024 | -6.41% |
| Jun 30, 2024 | -8.69% |
| Mar 31, 2024 | -12.53% |
| Dec 31, 2023 | -11.82% |
| Sep 30, 2023 | -19.06% |
| Jun 30, 2023 | 2.81% |
| Mar 31, 2023 | -0.81% |
| Dec 31, 2022 | 6.31% |
| Sep 30, 2022 | 4.64% |
| Jun 30, 2022 | 6.59% |
| Mar 31, 2022 | 1.11% |
| Dec 31, 2021 | 17.07% |
| Sep 30, 2021 | 17.38% |
| Jun 30, 2021 | 14.27% |
| Mar 31, 2021 | 14.75% |
| Dec 31, 2020 | 19.55% |
| Sep 30, 2020 | -19.62% |
| Jun 30, 2020 | -20.53% |
| Mar 31, 2020 | 7.81% |
| Dec 31, 2019 | -5.82% |
| Sep 30, 2019 | -20.69% |
| Jun 30, 2019 | -24.34% |
| Dec 31, 2018 | 0.87% |
| Sep 30, 2018 | -27.77% |